James F. Eliason
Chief Executive Officer at Central European Ventures LLC
Profile
James F.
Eliason is currently the Chief Executive & Scientific Officer at Central European Ventures LLC.
Prior to this, he worked as the Chief Scientific Officer at Asterand, Inc. and as a Principal at Hoffmann-La Roche, Inc.
James F. Eliason active positions
| Companies | Position | Start |
|---|---|---|
Central European Ventures LLC
 Central European Ventures LLC Investment ManagersFinance Central European Ventures LLC invests in private companies. The firm takes products from proof-of-concept to market for technologies originating from Central European countries. The company is headquartered in Grosse Pointe Park, MI. | Chief Executive Officer | 22/12/2009 |
Former positions of James F. Eliason
| Companies | Position | End |
|---|---|---|
Asterand, Inc.
 Asterand, Inc. Drugstore ChainsRetail Trade Asterand, Inc. is engaged in providing all the information and materials that are needed to conduct research on common disease targets, such as cancer, heart disease and brain disorders. The company is a privately held company founded in 2000 to address the urgent need of genomics and proteomics researchers for high quality biological information and materials. The customers of the company include researchers working at the world's foremost and oldest pharmaceutical, biotech, genomic and proteonic companies. | Chief Tech/Sci/R&D Officer | 04/01/2006 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Asterand, Inc.
Asterand, Inc. Drugstore ChainsRetail Trade Asterand, Inc. is engaged in providing all the information and materials that are needed to conduct research on common disease targets, such as cancer, heart disease and brain disorders. The company is a privately held company founded in 2000 to address the urgent need of genomics and proteomics researchers for high quality biological information and materials. The customers of the company include researchers working at the world's foremost and oldest pharmaceutical, biotech, genomic and proteonic companies. | Retail Trade |
Central European Ventures LLC
Central European Ventures LLC Investment ManagersFinance Central European Ventures LLC invests in private companies. The firm takes products from proof-of-concept to market for technologies originating from Central European countries. The company is headquartered in Grosse Pointe Park, MI. | Finance |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
- Stock Market
- Insiders
- James F. Eliason
